Integrated Biopharma Stock Price (OTCMKTS:INBP)

Add to My Stocks
$0.18 $0 (0%) INBP stock closing price Sep 18, 2018 (Closing)
Prev Close* : $0.18
Market Cap:
$3.7M
Day Low: $0
52 Week Low: $0.11
Open: $0
Volume: $0
Day High: $0
52 Week High: $0.22
Dividend:
0.00

Latest Stock Market News

Latest Articles

INBP Stockcharts

View INBP PE ratio, PS ratio stocks charts and compare with peers.
INBP Chart
Note: Compare Integrated Biopharma stock price history with the index and industry peers.

Integrated Biopharma Valuation

PE ratio
(price earnings ratio)
4.25
PS ratio (
price to sales ratio
)
0.08
PB ratio (
price to book ratio
)
-0.56

Integrated Biopharma Returns

ROE
(return on equity)
-

Integrated Biopharma Financial Ratios

Asset Turnover
2.79
Receivables Turnover
12.34
Debt to Equity
-
Dividend Yield
0%

INBP Industry Peers

Company Price Change (%)
Boston Therapeutics (BTHE)0.040.01 (20%)
Bio Blast Pharma (ORPN)1.280.03 (2.4%)
Aceto (ACET)2.90.03 (1.02%)
Cambrex (CBM)62.20.5 (0.8%)
Surmodics (SRDX)792.1 (2.73%)
Zogenix (ZGNX)48.650.15 (0.31%)
Catalent (CTLT)42.880.31 (0.73%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Integrated Biopharma Financial Statements

income statement20182017201620152014
Net Sales or Revenues43.71M46.95M42.21M37.48M33.68M
Net Income-2.34M---
Total Operating Expense3.29M3.48M3.39M3.46M3.53M
View Integrated Biopharma income statement
balance sheet20172016201520142013
Total Assets15.19M14.08M11.62M11.58M12.61M
Total Liabilities21.12M22.41M20.93M21.73M22.9M
Shareholders Equity-5.92M-8.32M-9.31M-10.15M-10.29M
View Integrated Biopharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.13M-2.2M-0.82M--2.45M
Net Cash from (used by) Operating Activities--0.59M-0.11M1.87M-1.43M
Increase (Decrease) in Prop Plant And Equipment-0.32M-0.1M-0.23M-0.18M-0.01M
View Integrated Biopharma cash flow statement

Integrated Biopharma Stock Message Board

As of last trading day, Integrated Biopharma stock price was $0.18. Looking at Integrated Biopharma market capitalization, which currently stands at $3.7M, we can say that INBP stock is a Nano Cap stock. Integrated Biopharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy INBP stock than sell it, then Integrated Biopharma stock price goes up. Conversely, if more investors wanted to sell INBP stock than buy it, there would be greater supply than demand, and the stock price would fall. 0 shares were traded with a closing stock price of $0.18 as of Sep 18, 2018, as can be seen from Integrated Biopharma stock quote. One can view Integrated Biopharma stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Integrated Biopharma dividend per share was 0.00 during the last quarter. Integrated Biopharma stock price history, gives the entire historical data for INBP stock.